Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo‐controlled study during the pollen season
Open Access
- 1 January 2015
- journal article
- research article
- Published by Wiley in Clinical and Translational Allergy
- Vol. 5 (1) , 41
Abstract
Background: The efficacy of Lactobacillus paracasei NCC 2461 in modulating allergic rhinitis was previously evaluated in two exploratory clinical studies. Oral administration with NCC 2461 reduced specific subjective symptoms following nasal provocation tests with controlled grass pollen allergen concentrations. Our aim was to confirm the anti‐allergic effect of NCC 2461 in grass pollen allergic subjects exposed to natural doses of allergens during the pollen season.Findings: A double‐blind, randomized, placebo‐controlled, parallel study was conducted with 131 grass pollen allergic subjects from May to July 2012 in concomitance with the pollen season in Berlin. NCC 2461 or placebo was administered daily for an 8‐week period to adult subjects with clinical history of allergic rhinitis to grass pollen, positive skin prick test and IgE to grass pollen. During the 8 weeks, symptoms and quality of life questionnaires were filled out, and plasma was collected for IgE analysis at screening and at the end of the intervention. All subjects were included within a 5‐day interval, ensuring exposure to similar air pollen counts for each individual during the trial period. The results obtained show that symptoms increased with pollen loads, confirming a natural exposure to the allergen and presence of pollen‐induced allergic rhinitis in the subjects. However, no significant differences were observed in allergic rhinitis symptoms scores, quality of life, or specific IgE levels between subjects receiving NCC 2461 as compared to placebo administration.Conclusion: In contrast to previous findings, oral administration of NCC 2461 did not show a beneficial effect on allergic rhinitis in a field trial. The influence of study design, allergen exposure and intervention window on the efficacy of NCC 2461 in modulating respiratory allergy should be further evaluated.Keywords
This publication has 31 references indexed in Scilit:
- Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study)European Journal of Clinical Nutrition, 2014
- Oral Delivery of a Probiotic Induced Changes at the Nasal Mucosa of Seasonal Allergic Rhinitis Subjects after Local Allergen Challenge: A Randomised Clinical TrialPLOS ONE, 2013
- Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen: an exploratory, randomized, placebo-controlled clinical trialEuropean Journal of Clinical Nutrition, 2013
- Allergic rhinitisThe Lancet, 2011
- Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Prevention and Management of Allergic Diseases by Probiotics1–3The Journal of Nutrition, 2010
- Burden of allergic rhinitis: Results from the Pediatric Allergies in America surveyJournal of Allergy and Clinical Immunology, 2009
- Allergic rhinitis: market evolutionNature Reviews Drug Discovery, 2009
- Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey IAllergy, 2007
- Clinical Effects of Lactobacillus acidophilus Strain L-92 on Perennial Allergic Rhinitis: A Double-Blind, Placebo-Controlled StudyJournal of Dairy Science, 2005
- Treatment of perennial allergic rhinitis with lactic acid bacteriaPediatric Allergy and Immunology, 2004